newsfilter
← Latest News
GlobeNewswire·

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Intellia Therapeutics awarded inducement grants to thirteen new employees on July 1, 2026, under its 2024 Inducement Plan.
  • The grants consisted of 53,250 time-based restricted stock units (RSUs) with one-third vesting annually over three years.
  • Vesting is contingent upon continued service as an employee or service provider through the applicable dates.
  • These awards were granted outside of stockholder-approved equity plans & approved by the compensation committee as a material inducement to employment.
  • The 2024 Inducement Plan was initially adopted by the board in June 2024 & complies with Nasdaq Listing Rule 5635(c)(4).